NCT05995132

Brief Summary

The intensive care unit (ICU) is recognizably detrimental to sleep and circadian health, and critical survivors frequently report the presence of alterations in this regard after hospital discharge. However, an appropriate evaluation of sleep and circadian rhythms is often neglected given the high associated cost and/or the need of collaboration of the patients. In this project, the investigators propose alternatives to ultimately improve the management of sleep and circadian health after critical illness. The researchers will evaluate the role of microRNA (miRNAs) expression profile in identifying the compromised sleep and circadian health of critical patients during the ICU stay, in the short (3 months after hospital discharge), and in the long-term (12 months after hospital discharge). Also, models based on machine learning techniques will be developed to predict adverse outcomes in this regard after hospital discharge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
271

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 16, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 27, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

1.2 years

First QC Date

August 9, 2023

Last Update Submit

September 26, 2023

Conditions

Keywords

microRNAcircadian rhythmsintensive care unitsleepcritical survivors

Outcome Measures

Primary Outcomes (2)

  • Sleep efficiency

    The sleep health of critical patients will be evaluated using this parameter, which will be obtained through 7 days of actigraphy at the 3- and 12-month follow-up. Sleep efficiency is defined as the ratio between total sleep time and the time spent in bed. The following cut-offs are used: i) sleep efficiency ≥ 85% (represents good sleep quality), ii) sleep efficiency \<85% (represents inappropriate sleep quality).

    12-month follow-up

  • Circadian function index (CFI)

    The circadian health of critical patients will be evaluated using this parameter, which will be obtained through 7 days of actigraphy at the 3- and 12-month follow-up. The circadian function index is defined as the average of intradaily variability, interdaily stability, and relative amplitude of the rhythm. There are no specific cut-offs for this parameter. The circadian function index values range from 0-1, in which 1 represents an appropriate circadian function.

    12-month follow-up

Study Arms (2)

Intensive care unit

This group will be composed of patients admitted to the intensive care unit who did not receive invasive mechanical ventilation.

Intensive care unit and invasive mechanical ventilation

This group will be composed of patients admitted to the intensive care unit who did receive invasive mechanical ventilation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critical patients admited to the intensive care unit of the Hospital Arnau de Vilanova de Lleida who meet the eligibility criteria.

You may qualify if:

  • Being older than 18 years old.
  • Intensive care unit admission.
  • Intensive care unit stay ≥7 days.

You may not qualify if:

  • Transference to another hospital during hospitalization or follow-up.
  • Mental or physical disability that could prevent the proposed evaluations.
  • Palliative care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari Arnau de Vilanova

Lleida, 25198, Spain

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

* 2 Tubes EDTA (6ml) * 1 tempus RNS tube (2,5 ml)

MeSH Terms

Conditions

Chronobiology DisordersSleep Deprivation

Condition Hierarchy (Ancestors)

Nervous System DiseasesDyssomniasSleep Wake DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Adriano Targa Dias Santos, PhD

    Institut de Recerca Biomèdica de Lleida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Adriano Targa Dias Santos, PhD

CONTACT

David de Gonzalo Calvo, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

August 9, 2023

First Posted

August 16, 2023

Study Start

September 27, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations